iwCLL 2023 | A strategy for curing CLL, one clone at a time
Varsha Gandhi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, presents the key points from a paper she has co-authored, titled ‘Curing chronic lymphocytic leukemia (CLL): one clone at a time’. This paper discusses the use of a strategy in which driver mutations (such as C481S and T474I) in the CLL cell population are not treated simultaneously, but rather sequentially, by sequencing covalent and non-covalent BTK inhibitors (BTKi’s) in a specific manner. This interview was recorded at the biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2023 meeting, held in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
